Table 5: Adjusted EBITDA and Free Cash Flow (unaudited)
| ($ in millions) | Three months ended | |||||||||||||
| June 28, 2020 | March 29, 2020 | June 30, 2019 | ||||||||||||
| Net income (loss) | $ | (209 | ) | $ | (13 | ) | $ | 46 | ||||||
| Reconciling items to adjusted net income | ||||||||||||||
| Financial (income) expense | 96 | 78 | 89 | |||||||||||
| (Benefit) provision for income taxes | (33 | ) | 2 | 21 | ||||||||||
| Depreciation | 136 | 133 | 128 | |||||||||||
| Amortization | 407 | 407 | 378 | |||||||||||
| Adjusted net income | $ | 397 | $ | 607 | $ | 662 | ||||||||
| Reconciling items to adjusted EBITDA | ||||||||||||||
| Results of equity-accounted investees | 1 | 1 | 1 | |||||||||||
| Purchase accounting effect on inventory | — | 17 | — | |||||||||||
| Restructuring | 8 | 11 | 5 | |||||||||||
| Stock based costs | 105 | 107 | 87 | |||||||||||
| Merger-related costs | 3 | 4 | 10 | |||||||||||
| Other incidental items | 3 | (107 | ) | 4 | ||||||||||
| Adjusted EBITDA | $ | 517 | $ | 640 | $ | 769 | ||||||||
| Trailing twelve month adjusted EBITDA | $ | 2,802 | $ | 3,054 | $ | 3,150 | ||||||||
| ($ in millions) | Three months ended | |||||||||||||
| June 28, 2020 | March 29, 2020 | June 30, 2019 | ||||||||||||
| Net cash provided by (used for) operating activities | $ | 414 | $ | 512 | $ | 517 | ||||||||
| Net capital expenditures on property, plant and equipment | (74 | ) | (143 | ) | (106 | ) | ||||||||
| Non-GAAP free cash flow | $ | 340 | $ | 369 | $ | 411 | ||||||||
| Non-GAAP free cash flow as percent of Revenue | 19 | % | 18 | % | 19 | % | ||||||||
